Skip to content

Drug interactions

Duloxetine + Glofitamab

Severity: Moderate

Duloxetine and Glofitamab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Glofitamab causes cytokine release syndrome, which can transiently suppress CYP enzyme activity. Duloxetine, cleared by CYP1A2 and CYP2D6, may therefore reach higher concentrations during and after CRS, increasing adverse effects.

What this interaction means in plain words

Duloxetine and Glofitamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Duloxetine belongs to Central Nervous System; Glofitamab belongs to Oncology.

Evidence level: Low

Why it happens

Cytokine-mediated suppression of CYP1A2 and CYP2D6 reduces duloxetine clearance.

What to do

Monitor for duloxetine adverse effects around the first doses and during any CRS. Adjust the duloxetine dose if toxicity occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Duloxetine and Glofitamab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Duloxetine with Glofitamab?

MediHelp rates the interaction as moderate. Duloxetine and Glofitamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Glofitamab causes cytokine release syndrome, which can transiently suppress CYP enzyme activity. Duloxetine, cleared by CYP1A2 and CYP2D6, may therefore reach higher concentrations during and after CRS, increasing adverse effects.

How serious is the interaction between Duloxetine and Glofitamab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for duloxetine adverse effects around the first doses and during any CRS. Adjust the duloxetine dose if toxicity occurs.

What other medicines interact with Duloxetine?

MediHelp also lists interactions of Duloxetine with, for example, Isocarboxazid, Linezolid, Methylene blue. The full list is on the Duloxetine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in